Concentrix (NASDAQ:CNXC) Stock Price Up 8% – Here’s Why

Posted by George Bondi on Jul 27th, 2026

Concentrix Corporation (NASDAQ:CNXC – Get Free Report) shares were up 8% during trading on Monday . The company traded as high as $23.90 and last traded at $24.0270. 209,455 shares traded hands during mid-day trading, a decline of 87% from the average session volume of 1,657,937 shares. The stock had previously closed at $22.25.

Analyst Ratings Changes

Several equities research analysts have issued reports on CNXC shares. Zacks Research downgraded Concentrix from a “hold” rating to a “strong sell” rating in a report on Thursday, July 2nd. Bank of America lowered their target price on Concentrix from $32.00 to $26.00 and set a “neutral” rating for the company in a research note on Tuesday, June 30th. Robert W. Baird reduced their price target on shares of Concentrix from $40.00 to $30.00 and set an “outperform” rating for the company in a report on Tuesday, June 30th. Canaccord Genuity Group lowered their target price on Concentrix from $55.00 to $45.00 and set a “buy” rating for the company in a report on Tuesday, June 30th. Finally, Weiss Ratings restated a “sell (d)” rating on shares of Concentrix in a report on Friday. Three research analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $32.75.

Read Our Latest Research Report on CNXC

Concentrix Stock Up 11.8%

The stock’s fifty day moving average price is $25.04 and its 200-day moving average price is $29.75. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 1.46. The company has a market capitalization of $1.52 billion, a price-to-earnings ratio of -1.17, a P/E/G ratio of 0.41 and a beta of 0.47.

Concentrix (NASDAQ:CNXC – Get Free Report) last announced its earnings results on Monday, June 29th. The company reported $2.63 EPS for the quarter, missing the consensus estimate of $2.64 by ($0.01). Concentrix had a positive return on equity of 19.82% and a negative net margin of 13.16%.The business had revenue of $2.46 billion for the quarter, compared to analyst estimates of $2.47 billion. During the same quarter in the previous year, the company posted $2.70 EPS. The business’s revenue for the quarter was up 1.9% compared to the same quarter last year. Concentrix has set its FY 2026 guidance at 10.830-11.180 EPS and its Q3 2026 guidance at 2.650-2.770 EPS. On average, sell-side analysts predict that Concentrix Corporation will post 9.67 earnings per share for the current fiscal year.

Concentrix Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, August 4th. Stockholders of record on Friday, July 24th will be issued a $0.36 dividend. The ex-dividend date is Friday, July 24th. This represents a $1.44 annualized dividend and a dividend yield of 5.8%. Concentrix’s dividend payout ratio (DPR) is presently -6.75%.

Insider Transactions at Concentrix

In related news, major shareholder Bruxelles Lambert Groupe sold 6,000,000 shares of the company’s stock in a transaction dated Wednesday, April 29th. The stock was sold at an average price of $22.25, for a total transaction of $133,500,000.00. Following the sale, the insider owned 2,773,667 shares in the company, valued at approximately $61,714,090.75. This represents a 68.39% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 0.90% of the company’s stock.

Institutional Investors Weigh In On Concentrix

Institutional investors and hedge funds have recently made changes to their positions in the stock. Larson Financial Group LLC grew its stake in shares of Concentrix by 224.9% in the third quarter. Larson Financial Group LLC now owns 692 shares of the company’s stock valued at $32,000 after buying an additional 479 shares in the last quarter. Geneos Wealth Management Inc. lifted its stake in Concentrix by 532.7% in the first quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock valued at $34,000 after acquiring an additional 522 shares during the last quarter. Global Retirement Partners LLC grew its position in shares of Concentrix by 1,032.5% in the 4th quarter. Global Retirement Partners LLC now owns 872 shares of the company’s stock valued at $36,000 after acquiring an additional 795 shares during the period. Allworth Financial LP grew its position in shares of Concentrix by 90.6% in the 3rd quarter. Allworth Financial LP now owns 856 shares of the company’s stock valued at $40,000 after acquiring an additional 407 shares during the period. Finally, Webster Bank N. A. acquired a new position in shares of Concentrix during the 1st quarter worth about $41,000. Institutional investors own 90.34% of the company’s stock.

Concentrix Company Profile

(Get Free Report)

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.